In a previous study, higher RBBP4 levels were noted in acute leukemia and blast crisis chronic myeloid leukemia than in non‐leukemic states and the chronic phase of chronic myeloid leukemia,43 suggesting an association with malignancy progression. This evidence concerns the gene RBBP4 and chronic myelogenous leukemia, BCR-ABL1 positive.